Rutgers Expert Available to Discuss Communicating About COVID-19 Vaccine

New Brunswick, N.J. (Sept. 17, 2020) – Rutgers University–New Brunswick Professor William Hallman is available for interviews on how to communicate with the public about a potential COVID-19 vaccine. “For a COVID-19 vaccine to be embraced by the public, officials can’t…

Athletes Should be Vaccinated Against Influenza

Athletes often fear undue side effects or a training-induced deficient immune response to vaccination – in particular when vaccination is carried out during ongoing training/competition. However, influenza is a virus disease which can lead to large health problems and interfere…

HPV Vaccinations During Global Pandemic

Human papillomavirus (HPV) is the most common sexually transmitted infection and the cause of most cervical cancers, and some vaginal, penile, anal and oral cancers. The HPV vaccine has proven effective in preventing infection and six types of HPV-attributable cancers. …

Early clinical trial supports tumor cell–based vaccine for mantle cell lymphoma

A phase I/II clinical trial by researchers at Stanford University suggests that vaccines prepared from a patient’s own tumor cells may prevent the incurable blood cancer mantle cell lymphoma (MCL) from returning after treatment. The study, which will be published June 19 in the Journal of Experimental Medicine (JEM), reveals that the vaccines are a safe and effective way to induce the body’s immune system to attack any tumor cells that could cause disease relapse.

UNLV Vaccination Expert Explores How Vaccine Refusal Might Change in Light of COVID-19

As governors across America begin to unveil and deploy plans to reopen their respective states, at the center of the debate a question has emerged: how soon is too soon? Some states, including Nevada and neighboring California, are taking a…

Anal cancer rates and mortality have risen dramatically among Americans

Rates of new anal cancer diagnoses and deaths related to human papillomavirus (HPV), the most common sexually transmitted infection, have increased dramatically over the last 15 years, according to researchers at The University of Texas Health Science Center at Houston (UTHealth). The results of their study will be published in the November issue of the Journal of the National Cancer Institute.